- Home
- SB vs FDMT Comparison
SB vs FDMT Comparison
Compare SB & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SB | FDMT |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | Monaco | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 773.9M | 695.3M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SB | FDMT |
|---|---|---|
| Price | $8.64 | $12.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | $9.50 | ★ $28.09 |
| AVG Volume (30 Days) | ★ 1.4M | 1.0M |
| Earning Date | 11-24-2026 | 11-09-2026 |
| Dividend Yield | ★ 2.81% | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $85,209,000.00 |
| Revenue This Year | $16.80 | N/A |
| Revenue Next Year | N/A | $55.65 |
| P/E Ratio | $16.77 | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $4.15 | $6.96 |
| 52 Week High | $9.31 | $16.93 |
Technical Indicators
Market Signals| Indicator | SB | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 52.08 | 41.78 |
| Support Level | $8.02 | $8.43 |
| Resistance Level | $9.19 | $14.00 |
| Average True Range (ATR) | 0.27 | 0.89 |
| MACD | -0.02 | -0.21 |
| Stochastic Oscillator | 64.97 | 20.78 |
Price Performance
Historical ComparisonAbout SB Safe Bulkers Inc ($0.001 par value)
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain, and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services. The company generates almost all of its revenue from Time Charters.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).